Do whole wheat and wheat bran help with constipation?

Wheat bran makes more stool and moves it faster, and for that there is pooled trial evidence. In four crossover trials in adults with normal bowels, it added 59.4 g of stool a day and cut transit time by 16.4 hours, though three of the four trials were at high risk of bias. Treating chronic constipation is a separate question with a much weaker answer. The 2023 US gastroenterology guideline found one small trial of bran, with a gain of 1.3 bowel movements a week and an interval that included no effect at all. It rated that evidence very low. Psyllium is better supported, and in irritable bowel syndrome pooled trials found no benefit from insoluble fiber such as bran.

Unsettled. For chronic constipation, bran has barely been tested by modern standards. The guideline panel found a single trial, worried about how it was randomized, and called the result very serious imprecision. The 2025 US agency review of bran in people with normal bowels found no trial that reported constipation itself as an outcome.

What the trials found

Bulk and speed, in people who were not constipated

On a metabolic ward, 60 people eating 20 g of wheat bran a day for 6 days produced 8.7 oz (246 g) of stool a day against 150 g on placebo, without more gut symptoms. Doubling the bran to 40 g worked no better than 20 g, and the stools did not get softer. In healthy men, about 20 g of added wheat fiber a day for 10 days took them from 1.1 to 1.3 bowel movements a day. That trial used an isolated wheat fiber product, which is not the same as the bran on a supermarket shelf.

Softer is not what bran reliably does. In the two trials that measured it in people with normal bowels, bran made stools firmer, by 0.4 to 1.1 points on the 7 point Bristol scale.

In chronic constipation

The one trial behind the guideline gave 20 g of bran a day for 4 weeks, double blind, in 24 people with chronic constipation. Bran beat placebo on how often people went and on transit time. Transit returned to normal only in those whose slow transit was in the colon, and not in those whose problem sat at the rectum. The symptoms that come with constipation were no different on bran than on placebo.

A 2026 network meta-analysis of 17 randomized trials in 1,423 adults with chronic constipation pooled bran into the wider class of insoluble fiber. That class ranked first for overall symptom score, on very low certainty evidence, and the abstract gives no separate figure for bran. Viscous soluble fiber such as psyllium did better than placebo for straining on high certainty evidence, and for stool consistency and frequency on moderate certainty.

Myth. Bran is often sold as the best fiber for constipation. In the newest pooled analysis the strongest evidence belongs to psyllium and other viscous soluble fibers, and the bran class ranks well only on evidence rated very low.

Whole wheat as a diet

For whole wheat as food, the evidence is one small open trial. In 39 young Korean women with functional constipation, 13 per group, a wheat based diet for 4 weeks cut total colon transit time by 17.1 hours while it rose 6.8 hours on a white rice diet. The comparison was white rice, there was no placebo, and the women knew what they were eating.

In pregnancy

A 2001 Cochrane review of 2 trials in pregnant women with constipation found fiber supplements raised how often they went, with an odds ratio of 0.18 for no improvement (95% CI 0.05 to 0.67). The abstract gives no absolute counts, so we cannot say how many women that represents. The reviewers concluded that bran or wheat fiber is likely to help.

Who should be careful

Not for everyone. If you have irritable bowel syndrome, bran is a poor first choice. A meta-analysis of 22 trials found soluble fiber improved symptoms with a risk ratio of 1.49 and insoluble fiber such as bran improved no outcome. In a 12 week primary care trial of 275 people, early dropout was highest on 10 g of bran, mostly because symptoms got worse.

Finely ground bran is a point of disagreement. The guideline says fine bran powder can lower stool water and harden stool. Two crossover trials in healthy adults found fine and coarse bran raised stool bulk equally with no difference in stool water. Flatulence is the main side effect of fiber supplements, according to the same guideline.

Fluid matters with the dose. The guideline notes that fiber supplements are usually taken with 8 to 10 ounces of fluid, and that people who drink little are more often constipated. In 20 low fiber eaters who doubled their fiber for 14 days with mixed sources including bran, drinking 2.1 quarts (2 liters) of water a day cut passing abdominal symptoms from 9 people to 3.

Bran also binds minerals. Eaten with a cereal containing 16 g of wheat bran, calcium absorption stayed near 23% at every dose, against 38 to 77% when the same calcium came without bran. Standard bran blocked the rise in blood zinc after a 50 mg zinc dose almost completely. Both studies gave the mineral at the same meal as the bran, so they say nothing about doses taken at other times.

What expert bodies say

The 2023 guideline from the American Gastroenterological Association and the American College of Gastroenterology says it is very uncertain about the effects of bran in chronic constipation, and rates the certainty of the evidence very low. The European Union authorizes two claims for wheat bran fiber, that it contributes to faster intestinal transit and to more fecal bulk. Neither claim mentions constipation.

How much bran the trials used

The trials above mostly used about 20 g of bran a day. The amount people report eating when the US survey records wheat bran without a portion is 8 g, which carries about 3.4 g of fiber.

How we searched

What would change this answer

• A modern randomized trial of wheat bran against psyllium and placebo in adults with chronic constipation. We found no such trial registered on ClinicalTrials.gov.
• A trial that reports bran's effect on constipation itself, as people experience it. The trials in people with normal bowels measured weight and transit, and the US agency review found none that reported constipation as an outcome.
• A direct test of fine against coarse bran in constipated people, which would settle whether the guideline's warning about fine powder holds.

More on the food itself, including its fiber and mineral content: wheat bran.

Sources

1. ev-wbcon-01 · Meta-analysis or systematic review · systematic review and network meta-analysis of RCTs · n = 1423
   Insoluble dietary fibers showed the highest ranking probability for improvement in overall constipation symptom scores; however, this finding was supported by very low certainty evidence.
   
   Who: adults with chronic idiopathic constipation in 17 randomized controlled trials, searched to October 2025
   Effect: insoluble fiber top SUCRA rank for overall symptom score (very low certainty); viscous soluble fibers better for straining (high certainty), stool consistency and frequency (moderate)
   Certainty: The latest synthesis. Wheat bran in it is part of the "insoluble" class; no separate rating for bran in the abstract.
   Food Funct, 2026 · checked 2026-10-07 · we read the abstract
2. ev-wbcon-02 · Meta-analysis or systematic review · systematic review and network meta-analysis of RCTs · n = 1423
   NMA suggested that viscous soluble fibers were associated with greater efficacy compared with placebo in relieving defecation difficulty (high certainty, class 1), and were also associated with improvements in stool consistency and stool frequency relative to placebo (moderate certainty, class 1).
   
   Who: adults with chronic idiopathic constipation in 17 randomized controlled trials
   Effect: viscous soluble fiber vs placebo: defecation difficulty improved (high certainty, class 1); stool consistency and frequency improved (moderate certainty)
   Certainty: Answers the myth "bran is the best fiber for constipation": viscous soluble fibers are better established.
   Food Funct, 2026 · checked 2026-10-07 · we read the abstract
3. ev-wbcon-03 · Position of an expert body · professional society guideline with GRADE systematic review · n = 1 trial
   Based on this 1 small study, bran may lead to an increase in SBMs per week; however, the CI was wide and included a possible null effect (MD 1.30, CI −0.98 to 3.58) (26).
   
   Who: adults with chronic idiopathic constipation; one small crossover RCT
   Effect: spontaneous bowel movements per week MD 1.30 (95% CI -0.98 to 3.58); 1 adverse event vs 0 (RR 2.79, 0.12 to 62.48)
   Certainty: Authority position with its own GRADE analysis of a single RCT (Badiali 1995, see ev-wbcon-05). Level E by the rule for guidelines.
   Am J Gastroenterol, 2023 · checked 2026-10-07 · we read the fulltext
4. ev-wbcon-04 · Position of an expert body · professional society guideline with GRADE systematic review · n = —
   We are very uncertain about the effects of bran. The overall certainty of evidence for bran is very low because of concerns about the adequacy of randomization and allocation concealment as well as very serious imprecision (26).
   
   Who: adults with chronic idiopathic constipation
   Effect: certainty of evidence very low
   Certainty: Axis 9: in chronic constipation, bran has hardly been studied in modern RCTs.
   Am J Gastroenterol, 2023 · checked 2026-10-07 · we read the fulltext
5. ev-wbcon-05 · Randomized controlled trial(s) · randomized double-blind placebo-controlled crossover trial · n = 24
   During bran treatment oroanal transit time became normal only in patients with slow colonic transit and not in those with slow rectal transit.
   
   Who: 24 patients with chronic nonorganic constipation, crossover, two 4-week periods
   Effect: bran 20 g/day superior to placebo for bowel frequency and oroanal transit; transit normalized only with slow colonic (not rectal) transit; symptoms no different from placebo
   Certainty: Small RCT from 1995; placebo also improved frequency. Axis 8: with slow rectal transit (defecation dysfunction), bran did not normalize transit.
   Dig Dis Sci, 1995 · checked 2026-10-07 · we read the abstract
6. ev-wbcon-06 · Randomized controlled trial(s) · randomized double-blind placebo-controlled crossover trial · n = 24
   Neither the occurrence nor the severity of the most frequent accompanying symptoms of chronic constipation differed significantly between placebo and bran treatments.
   
   Who: 24 patients with chronic nonorganic constipation
   Effect: occurrence and severity of accompanying symptoms not different between bran and placebo
   Dig Dis Sci, 1995 · checked 2026-10-07 · we read the abstract
7. ev-wbcon-07 · Meta-analysis or systematic review · Cochrane systematic review of RCTs · n = 2 trials
   Dietary supplements of fibre in the form of bran or wheat fibre are likely to help women experiencing constipation in pregnancy.
   
   Who: pregnant women with constipation, 2 randomized trials
   Effect: fiber supplements increased defecation frequency (OR 0.18, 95% CI 0.05 to 0.67) and softened stools
   Certainty: 2001 version; the 2015 update (26342714, already in ev-fibc) gives MD 2.24 bowel movements per week in 40 women, moderate quality. Bran is named specifically here.
   Cochrane Database Syst Rev, 2001 · checked 2026-10-07 · we read the abstract
8. ev-wbcon-08 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = 22 trials
   Soluble fiber appears to improve symptoms of IBS, whereas there is no evidence for recommending insoluble fiber for IBS.
   
   Who: outpatients with irritable bowel syndrome in randomized and crossover trials vs placebo
   Effect: soluble fiber RR 1.49 (95% CI 1.09 to 2.03) for global symptoms; insoluble fiber no improvement in any outcome
   Certainty: Constipation in IBS is a frequent query; bran is not recommended here. Consistent with 14984370 (whbr-r2-09).
   Eur J Gastroenterol Hepatol, 2015 · checked 2026-10-07 · we read the abstract
9. ev-wbcon-09 · Randomized controlled trial(s) · randomized placebo-controlled trial · n = 275
   Early dropout was most common in the bran group; the main reason was that the symptoms of irritable bowel syndrome worsened.
   
   Who: 275 patients aged 18 to 65 with irritable bowel syndrome in general practice
   Effect: bran vs placebo responders month 3: 57% vs 32%, RR 1.70 (1.12 to 2.57), not significant in worst case analysis (1.45, 0.97 to 2.16); psyllium effective from month 1
   Certainty: Axis 6: for people with IBS, bran may worsen symptoms; psyllium is a better alternative.
   BMJ, 2009 · checked 2026-10-07 · we read the abstract
10. ev-wbcon-10 · Position of an expert body · professional society guideline · n = —
    In addition, wheat bran can exist as a finely ground powder that can decrease stool water content and harden stool (34). The chief side effect of fiber supplementation seems to be flatulence.
    
    Who: adults with chronic idiopathic constipation
    Effect: fine bran powder may harden stool; flatulence the chief side effect
    Certainty: RCT 12038477 (ev-wbcon-12) found no difference in stool water between grinds; the discrepancy remains.
    Am J Gastroenterol, 2023 · checked 2026-10-07 · we read the fulltext
11. ev-wbcon-11 · Position of an expert body · professional society guideline · n = —
    Thus, efforts to increase fluid intake should be focused on those with low levels of fluid intake (35). Standard doses of fiber supplements are typically taken with 8–10 ounces of fluid (36).
    
    Who: adults with chronic constipation
    Effect: standard fiber dose taken with 8 to 10 oz (about 240 to 300 ml) of fluid
    Am J Gastroenterol, 2023 · checked 2026-10-07 · we read the fulltext
12. ev-wbcon-12 · Randomized controlled trial(s) · randomized crossover trials · n = 47
    In both studies, wheat bran supplements significantly increased fecal bulk compared to the control (p<0.004), with no significant differences between brans of different particle size and no differences in fecal water content.
    
    Who: healthy adults, metabolic study n=23 and ad libitum cereal study n=24
    Effect: fecal bulk increased vs control (p<0.004) with fine and coarse bran; no difference between particle sizes or in fecal water
    Certainty: Healthy people, not constipation. Contradicts the AGA caution about fine grinding (ev-wbcon-10).
    J Am Coll Nutr, 1999 · checked 2026-10-07 · we read the abstract
13. ev-wbcon-13 · Randomized controlled trial(s) · placebo-controlled parallel randomized trial · n = 60
    Wheat bran 40 g/day results were not significantly different from wheat bran 20 g/day.
    
    Who: 60 subjects on a metabolic ward, 3 days baseline and 6 days treatment
    Effect: stool output placebo 150 vs bran 246 g/day (p<0.05); BM/day 2.2 vs 2.6; no stool softening; 40 g/day not different from 20 g/day
    Certainty: Dose plateau: more than 20 g of bran per day added no benefit. Participants without constipation.
    Am J Gastroenterol, 2000 · checked 2026-10-07 · we read the abstract
14. ev-wbcon-14 · Randomized controlled trial(s) · double-blind randomized crossover trial · n = —
    Extrinsic wheat fibre intervention furthermore increased stool frequency (1.3 ± 0.1 defecations per day compared to 1.1 ± 0.1 defecations per day during control diet, p < 0.05), but did not affect stool consistency, satiety, gastrointestinal complaints or product liking.
    
    Who: healthy male volunteers, meal boxes for 10 days
    Effect: stool frequency 1.3 vs 1.1 defecations/day (p<0.05); fecal wet weight x1.41, dry weight x1.55; consistency and GI complaints unchanged
    Certainty: Isolated wheat fiber (VITACEL), not whole bran; people without constipation.
    Food Funct, 2019 · checked 2026-10-07 · we read the abstract
15. ev-wbcon-15 · Randomized controlled trial(s) · open randomized controlled parallel trial · n = 39
    The TCTT of the BRD group was significantly reduced (p = 0.028) compared with the WRD group (-16.5 ± 8.1 vs +6.8 ± 2.1), and the TCTT of the WD group was also significantly reduced (p = 0.022) compared with that of the WRD group (-17.1 ± 11.9 vs +6.8 ± 2.1).
    
    Who: 39 young women with functional constipation, 13 per group, open randomized parallel design, 4 weeks
    Effect: total colon transit time wheat diet -17.1 ± 11.9 h vs white rice +6.8 ± 2.1 h (p=0.022)
    Certainty: Answers "whole wheat": comparison with white rice, not with placebo; open-label, small.
    Eur J Clin Nutr, 2020 · checked 2026-10-07 · we read the abstract
16. whbr-r2-03 · Position of an expert body · national food survey portion dataset · n = —
    Wheat bran, fdc_id 2708488: 1 cup 60 g; Quantity not specified 8 g; Fiber, total dietary 42.8 G per 100 g
    
    Who: USDA FNDDS portion weights for 'Wheat bran', food code 57601100
    Effect: 1 cup 60 g (25.7 g fiber); quantity not specified 8 g (3.4 g fiber), recalculated from 100 g
    Certainty: per-portion fiber is a recalculation
    USDA FoodData Central, FNDDS survey foods release 2024-10-31 · checked 2026-09-30 · we read the dataset
17. whbr-r2-04 · Meta-analysis or systematic review · agency systematic review and meta-analysis of crossover RCTs · n = —
    Meta-analysis across the five trials, not accounting for fiber dose, found a statistically significant higher total fecal weight (59.4 g/day; 95% CI 28.5 to 90.3) when consuming wheat bran (Figure 34).
    
    Who: adults with normal bowel function, four crossover RCTs, 2 to 3 weeks per intervention
    Effect: total fecal weight +59.4 g/day (95% CI 28.5 to 90.3), dose slope 3.3 g per g/day fiber (95% CI 1.69 to 4.98)
    Certainty: three of four trials high risk of bias, I2 90%
    AHRQ 2025, Fiber Intake and Laxation in People With Normal Bowel Function: Systematic Review · checked 2026-09-30 · we read the section
18. whbr-r2-05 · Meta-analysis or systematic review · agency systematic review and meta-analysis of crossover RCTs · n = —
    Meta-analysis, not accounting for fiber dose, identified a statistically significant shorter transit time with consumed wheat bran of −16.4 hours (95% CI −29.3 to −3.4) (Figure 36).
    
    Who: adults with normal bowel function, four crossover RCTs, 2 to 3 weeks
    Effect: transit time -16.4 h (95% CI -29.3 to -3.4), not dose-related
    Certainty: one trial went the other way, I2 85%
    AHRQ 2025, Fiber Intake and Laxation in People With Normal Bowel Function: Systematic Review · checked 2026-09-30 · we read the section
19. whbr-r2-06 · Meta-analysis or systematic review · agency systematic review and meta-analysis of crossover RCTs · n = —
    In both trials stool consistency was harder for participants ingesting wheat bran, with MD between arms ranging from −1.1 to −0.4 (standardized to the 7-point BSS).
    
    Who: adults with normal bowel function, three wheat bran arms in two trials
    Effect: stool consistency harder with bran in both trials, mean differences between arms -1.1 to -0.4 on the 7-point Bristol scale
    Certainty: two small trials, I2 66%
    AHRQ 2025, Fiber Intake and Laxation in People With Normal Bowel Function: Systematic Review · checked 2026-09-30 · we read the section
20. whbr-r2-07 · Meta-analysis or systematic review · agency systematic review and meta-analysis of crossover RCTs · n = —
    No trials of wheat bran reported data for constipation.
    
    Who: trials of wheat bran fiber vs no added fiber
    Effect: zero trials with constipation outcome
    Certainty: gap statement; constipation evidence comes from other populations
    AHRQ 2025, Fiber Intake and Laxation in People With Normal Bowel Function: Systematic Review · checked 2026-09-30 · we read the section
21. whbr-r2-09 · Meta-analysis or systematic review · systematic review and meta-analysis of RCTs · n = —
    Soluble fibre (psyllium, ispaghula, calcium polycarbophil) showed significant improvement (relative risk, 1.55; 95% CI, 1.35-1.78), whereas insoluble fibre (corn, wheat bran), in some cases, worsened the clinical outcome, but there was no significant difference compared with placebo (relative risk, 0.89; 95% CI, 0.72-1.11).
    
    Who: patients with irritable bowel syndrome in 17 randomized trials, secondary care
    Effect: insoluble fiber RR 0.89 (95% CI 0.72 to 1.11) for global symptom relief vs soluble fiber RR 1.55
    Certainty: 2004 review, no primary care patients
    Aliment Pharmacol Ther, 2004 · checked 2026-09-30 · we read the abstract
22. whbr-r2-10 · Randomized controlled trial(s) · randomized crossover trial · n = —
    In contrast, fractional absorption from calcium carbonate co-ingested with 40 g of a cereal product containing 16 g wheat bran, across a calcium load range from 0.5 to 15.5 mmol, was essentially constant (mean for all loads: 0.230 +/- 0.069).
    
    Who: healthy adult women, randomized crossover, calcium carbonate labeled with 45Ca
    Effect: fractional absorption 0.230 with bran vs 0.769 (0.5 mmol) to 0.378 (12.5 mmol) without
    Certainty: number of women not given in the abstract
    J Nutr, 1996 · checked 2026-09-30 · we read the abstract
23. whbr-r2-11 · Randomized controlled trial(s) · randomized comparative absorption study · n = —
    The percentage reductions in AUC produced by the test meals were: standard bran 106.4 +/- 2.4, reduced phytate bran 75.9 +/- 4.8, Rice Krispies 46.3 +/- 10.4 per cent, P less than 0.01).
    
    Who: three groups of healthy subjects given 50 mg zinc with or without a bran cereal
    Effect: AUC reduction 106.4% with standard bran vs 75.9% with reduced phytate bran vs 46.3% with a rice cereal
    Certainty: pharmacological zinc dose, 1989
    Eur J Clin Nutr, 1989 · checked 2026-09-30 · we read the abstract
24. whbr-r2-16 · Randomized controlled trial(s) · randomized phase 2 trial · n = 20
    Transient abdominal symptoms occurred less frequently in the fibre/water than in the fibre group (3 vs. 9 participants; p = 0.020).
    
    Who: 20 healthy low-habitual fiber consumers, 14 days, fiber with or without 2 l water daily
    Effect: abdominal symptoms 3 vs 9 participants (P = 0.020); fecal weight 71 to 126 g in the water group
    Certainty: mixed fiber sources, small
    Int J Food Sci Nutr, 2022 · checked 2026-09-30 · we read the abstract
25. whbr-r2-17 · Position of an expert body · regulatory register entry · n = —
    POL-HC-6528 Wheat bran fibre Wheat bran fibre contributes to an acceleration of intestinal transit Authorised
    
    Who: EU Register on nutrition and health claims
    Effect: status authorized
    Certainty: conditions of use (at least 10 g wheat bran fiber a day) sit in Regulation 432/2012, not in this register row
    EU Register on nutrition and health claims, claim POL-HC-6528, snapshot 2026-09-21 · checked 2026-09-30 · we read the dataset
26. whbr-r2-18 · Position of an expert body · regulatory register entry · n = —
    POL-HC-6529 Wheat bran fibre Wheat bran fibre contributes to an increase in faecal bulk Authorised
    
    Who: EU Register on nutrition and health claims
    Effect: status authorized
    Certainty: conditions of use sit in Regulation 432/2012
    EU Register on nutrition and health claims, claim POL-HC-6529, snapshot 2026-09-21 · checked 2026-09-30 · we read the dataset